India Globalization Capital, Inc. (NYSE: IGC) – The Pros are Already Picking Horses
Alzheimer's is America’s most expensive disease, with a new diagnosis every 66 seconds IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise Low market cap could make IGC a big winner for early investors Alzheimer's disease is one of the greatest medical, ethical, and financial challenges facing society today. Currently, more than 5.3 million Americans and their families have to deal with Alzheimer's disease, and projections suggest that number will nearly triple to 14 million Americans by 2050. Globally, the figures are even more staggering, with about 47 million people worldwide currently diagnosed and…






